Showing results (1-10 of 952) with videos related to
Sort By:
Pageof 96
Circulation|June 17, 2009
Soluble CXCL16 predicts long-term mortality in acute coronary syndromesAnna M Jansson, Pål Aukrust, Thor Ueland, et al.Journal of the American College of Cardiology|August 10, 2019
Homeostatic Chemokines and Prognosis in Patients With Acute Coronary SyndromesKenneth Caidahl, Marianne Hartford, Annica Ravn-Fischer, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|October 2, 2012
Multimarker risk assessment including osteoprotegerin and CXCL16 in acute coronary syndromesAnna M Jansson, Marianne Hartford, Torbjørn Omland, et al.Current Diabetes Reports|February 17, 2016
Impact of Systemic Inflammation on the Progression of Gestational Diabetes MellitusTove Lekva, Errol R Norwitz, Pål Aukrust, et al.Journal of the American College of Cardiology|February 12, 2008
Circulating osteoprotegerin levels and long-term prognosis in patients with acute coronary syndromesTorbjørn Omland, Thor Ueland, Anna M Jansson, et al.International Journal of Cardiology|April 7, 2018
Serum neutrophil gelatinase-associated lipocalin (NGAL) concentration is independently associated with mortality in patients with acute coronary syndromeStåle H Nymo, Marianne Hartford, Thor Ueland, et al.Fundamental & Clinical Pharmacology|November 16, 2007
The role of statins in heart failureLars Gullestad, Erik Oie, Thor Ueland, et al.Heart Failure Monitor|March 21, 2006
Anti-inflammatory trials in chronic heart failurePål Aukrust, Arne Yndestad, Thor Ueland, et al.Current Heart Failure Reports|March 29, 2012
TNF revisited: osteoprotegerin and TNF-related molecules in heart failureThor Ueland, Arne Yndestad, Christen P Dahl, et al.Annals of Medicine|July 20, 2005
Inflammatory and anti-inflammatory cytokines in chronic heart failure: potential therapeutic implicationsPål Aukrust, Lars Gullestad, Thor Ueland, et al.Pageof 96